“…Endometrial sampling is recommended in conjunction with colposcopy and endocervical sampling in women 35 years of age and older with all subcategories of AGC and AIS. In women with biopsyproven CIN 2 during pregnancy, the risk of microinvasive cancer at the postpartum visit is negligible, whereas the risk after CIN 3 is substantially less than 10%, and deeply invasive types of cancer are rare (158,159). During pregnancy, limiting biopsy to lesions suspicious for CIN 2,3 or cancer is preferred, but biopsy of any lesion is acceptable.…”